Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › Other

Original language	English
Pages (from-to)	2117-2118
Number of pages	2
Journal	Rheumatology International
Volume	40
Issue number	12
DOIs	https://doi.org/10.1007/s00296-020-04715-0
Publication status	Published - 1 Dec 2020
Externally published	Yes

Access to Document

@article{84746df71a294272a16add7c75b744c1,

title = "Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = dec,

day = "1",

doi = "10.1007/s00296-020-04715-0",

language = "English",

volume = "40",

pages = "2117--2118",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer",

number = "12",

}

TY - JOUR

T1 - Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85092386047&partnerID=8YFLogxK

U2 - 10.1007/s00296-020-04715-0

DO - 10.1007/s00296-020-04715-0

M3 - Letter

C2 - 33044704

AN - SCOPUS:85092386047

SN - 0172-8172

VL - 40

SP - 2117

EP - 2118

JO - Rheumatology International

JF - Rheumatology International

IS - 12

ER -